Nijmegen is the oldest city in the Netherlands and one of the places where the disease-causing repeat expansion was identified in the nineties. OPTIMISTIC, the largest myotonic dystrophy trial, was initiated and coordinated in Nijmegen.
The meeting will offer an excellent opportunity to learn, share, and network with all those currently active in the field of myotonic dystrophy: scientists, clinicians, patients, patient representatives, and professionals from the pharmaceutical industry.
IDMC-14 promises to be a truly unique experience, with cutting-edge presentations, interactive sessions, and engaging discussions that will challenge and inspire you. Participants will have the chance to connect with peers and experts from around the world, exchanging knowledge and ideas that will drive innovation and advancement in our field.
More information and registration at: www.idmc14.org